Skip to Main Content

Paper Details

A DREAM Challenge to Build Prediction Models for Short-Term Discontinuation of Docetaxel in Metastatic Castration-Resistant Prostate Cancer.
JCO Clin Cancer Inform
12
2017
Author NameAffiliation
Stephen R PiccoloTurku Centre for Biotechnology University of Turku Abo Akademi University, University of Kansas Medical Center, University of Texas Southwestern Medical Center, Brigham Young University, Provo University of Utah, University of Alberta Alberta Innovates Centre for Machine Learning, Neuherberg Technische Universitat Munchen, The Hebrew University, SAS Institute, University of Colorado, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, Prostate Cancer Foundation, University of California, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Tulane University
Russell D WolfingerTurku Centre for Biotechnology University of Turku Abo Akademi University, University of Kansas Medical Center, University of Texas Southwestern Medical Center, Brigham Young University, Provo University of Utah, University of Alberta Alberta Innovates Centre for Machine Learning, Neuherberg Technische Universitat Munchen, The Hebrew University, SAS Institute, University of Colorado, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, Prostate Cancer Foundation, University of California, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Tulane University
Russell D WolfingerTurku Centre for Biotechnology University of Turku Abo Akademi University, University of Kansas Medical Center, University of Texas Southwestern Medical Center, Brigham Young University, Provo University of Utah, University of Alberta Alberta Innovates Centre for Machine Learning, Neuherberg Technische Universitat Munchen, The Hebrew University, SAS Institute, University of Colorado, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, Prostate Cancer Foundation, University of California, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Tulane University
James Christopher BareTurku Centre for Biotechnology University of Turku Abo Akademi University, University of Kansas Medical Center, University of Texas Southwestern Medical Center, Brigham Young University, Provo University of Utah, University of Alberta Alberta Innovates Centre for Machine Learning, Neuherberg Technische Universitat Munchen, The Hebrew University, SAS Institute, University of Colorado, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, Prostate Cancer Foundation, University of California, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Tulane University
Elias Chaibub NetoTurku Centre for Biotechnology University of Turku Abo Akademi University, University of Kansas Medical Center, University of Texas Southwestern Medical Center, Brigham Young University, Provo University of Utah, University of Alberta Alberta Innovates Centre for Machine Learning, Neuherberg Technische Universitat Munchen, The Hebrew University, SAS Institute, University of Colorado, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, Prostate Cancer Foundation, University of California, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Tulane University
Thea NormanTurku Centre for Biotechnology University of Turku Abo Akademi University, University of Kansas Medical Center, University of Texas Southwestern Medical Center, Brigham Young University, Provo University of Utah, University of Alberta Alberta Innovates Centre for Machine Learning, Neuherberg Technische Universitat Munchen, The Hebrew University, SAS Institute, University of Colorado, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, Prostate Cancer Foundation, University of California, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Tulane University
Howard I ScherTurku Centre for Biotechnology University of Turku Abo Akademi University, University of Kansas Medical Center, University of Texas Southwestern Medical Center, Brigham Young University, Provo University of Utah, University of Alberta Alberta Innovates Centre for Machine Learning, Neuherberg Technische Universitat Munchen, The Hebrew University, SAS Institute, University of Colorado, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, Prostate Cancer Foundation, University of California, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Tulane University
Oliver SartorTurku Centre for Biotechnology University of Turku Abo Akademi University, University of Kansas Medical Center, University of Texas Southwestern Medical Center, Brigham Young University, Provo University of Utah, University of Alberta Alberta Innovates Centre for Machine Learning, Neuherberg Technische Universitat Munchen, The Hebrew University, SAS Institute, University of Colorado, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, Prostate Cancer Foundation, University of California, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Tulane University
Justin GuinneyTurku Centre for Biotechnology University of Turku Abo Akademi University, University of Kansas Medical Center, University of Texas Southwestern Medical Center, Brigham Young University, Provo University of Utah, University of Alberta Alberta Innovates Centre for Machine Learning, Neuherberg Technische Universitat Munchen, The Hebrew University, SAS Institute, University of Colorado, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, Prostate Cancer Foundation, University of California, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Tulane University
Justin GuinneyTurku Centre for Biotechnology University of Turku Abo Akademi University, University of Kansas Medical Center, University of Texas Southwestern Medical Center, Brigham Young University, Provo University of Utah, University of Alberta Alberta Innovates Centre for Machine Learning, Neuherberg Technische Universitat Munchen, The Hebrew University, SAS Institute, University of Colorado, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, Prostate Cancer Foundation, University of California, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Tulane University
James C CostelloTurku Centre for Biotechnology University of Turku Abo Akademi University, University of Kansas Medical Center, University of Texas Southwestern Medical Center, Brigham Young University, Provo University of Utah, University of Alberta Alberta Innovates Centre for Machine Learning, Neuherberg Technische Universitat Munchen, The Hebrew University, SAS Institute, University of Colorado, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, Prostate Cancer Foundation, University of California, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Tulane University
  • 1 - 11

Datasets